Role of ayurved medicine in madhumeha(diabetes mellitus)

Role of basti and katak kharidhdi kasaya in madhumeha (diabetes mellitus type 2) and gut microbiome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030505

Enrollment

Registered

2021-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: 1)katak khadiradi kasaya: 1)katak khadiradi kasaya 40ml BD before meal for 21 days Intervention2: 2) Somvalkaladi basti: 2)Somvalkaladi basti 300ml per rectal for 7 days Intervention3:

Eligibility

Inclusion criteria

Inclusion criteria: patients fulfilling the diagnostic criteria for diabetes mellitud framed by WHO will be adopted

Exclusion criteria

Exclusion criteria: Complication of DM like nephropathy,cardiomypathy,retinopathy and other cronic disease

Design outcomes

Primary

Measure	Time frame
Reduction in HbA1c levels by 0.5% as compared to basal values,reduction in blood sugar (fasting and PP) levels by more tgen 25% in the ayurvedic intervention group as compared control group at the end of 21 days of treatment,improvment in sign and symptoms score by more then 10%Timepoint: 21 days	—

Secondary

Measure	Time frame
improvement n insulin sensitivity as determined by indices of insulin sensitivityTimepoint: 21 days	—

Countries

India

Contacts

Public ContactProf O P singh

Institute of medical science,Banaras hindu univercity

singhopbhu@gmail.com9415818732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026